Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
13,708,253
-
Shares change
-
+2,617,921
-
Total reported value, excl. options
-
$13,023,000
-
Value change
-
+$2,418,181
-
Number of buys
-
13
-
Number of sells
-
-14
-
Price
-
$0.9501
Significant Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q2 2021
39 filings reported holding ZSAN - ZOSANO PHARMA CORP - COM NEW as of Q2 2021.
ZOSANO PHARMA CORP - COM NEW (ZSAN) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,708,253 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (4,227,922 shares), Aisling Capital Management LP (2,718,226 shares), BlackRock Inc. (2,036,413 shares), RENAISSANCE TECHNOLOGIES LLC (1,351,806 shares), GEODE CAPITAL MANAGEMENT, LLC (887,153 shares), GSA CAPITAL PARTNERS LLP (879,829 shares), STATE STREET CORP (418,916 shares), BARCLAYS PLC (200,000 shares), NORTHERN TRUST CORP (199,497 shares), and Telemetry Investments, L.L.C. (185,000 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.